236 related articles for article (PubMed ID: 17663183)
1. Synthesis of 6beta-D-glucosyl and 6-nitroxy (-)-galanthamine derivatives as acetylcholinesterase inhibitors.
Perissutti E; Fiorino F; Severino B; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
Pharmazie; 2007 Jun; 62(6):403-5. PubMed ID: 17663183
[TBL] [Abstract][Full Text] [Related]
2. Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of alkylene linked bis-galanthamine and galanthamine-galanthaminium salts.
Guillou C; Mary A; Renko DZ; Gras E; Thal C
Bioorg Med Chem Lett; 2000 Apr; 10(7):637-9. PubMed ID: 10762042
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of open D-Ring galanthamine analogues.
Herlem D; Martin MT; Thal C; Guillou C
Bioorg Med Chem Lett; 2003 Jul; 13(14):2389-91. PubMed ID: 12824041
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of galanthamine derivatives as acetylcholinesterase inhibitors.
Jia P; Sheng R; Zhang J; Fang L; He Q; Yang B; Hu Y
Eur J Med Chem; 2009 Feb; 44(2):772-84. PubMed ID: 18550228
[TBL] [Abstract][Full Text] [Related]
5. The Synthesis of Certain Derivatives and Analogues of (-)- and (+)-Galanthamine and an Assessment of their Capacities to Inhibit Acetylcholine Esterase.
Buckler JN; Taher ES; Fraser NJ; Willis AC; Carr PD; Jackson CJ; Banwell MG
J Org Chem; 2017 Aug; 82(15):7869-7886. PubMed ID: 28671462
[TBL] [Abstract][Full Text] [Related]
6. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.
Bores GM; Huger FP; Petko W; Mutlib AE; Camacho F; Rush DK; Selk DE; Wolf V; Kosley RW; Davis L; Vargas HM
J Pharmacol Exp Ther; 1996 May; 277(2):728-38. PubMed ID: 8627552
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase.
Boyle NA; Talesa V; Giovannini E; Rosi G; Norton SJ
J Med Chem; 1997 Sep; 40(19):3009-13. PubMed ID: 9301662
[TBL] [Abstract][Full Text] [Related]
9. The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design.
Greenblatt HM; Guillou C; Guénard D; Argaman A; Botti S; Badet B; Thal C; Silman I; Sussman JL
J Am Chem Soc; 2004 Dec; 126(47):15405-11. PubMed ID: 15563167
[TBL] [Abstract][Full Text] [Related]
10. Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity.
Atanasova M; Stavrakov G; Philipova I; Zheleva D; Yordanov N; Doytchinova I
Bioorg Med Chem; 2015 Sep; 23(17):5382-9. PubMed ID: 26260334
[TBL] [Abstract][Full Text] [Related]
11. Preparation of secolycorines against acetylcholinesterase.
Lee SS; Venkatesham U; Rao CP; Lam SH; Lin JH
Bioorg Med Chem; 2007 Jan; 15(2):1034-43. PubMed ID: 17085051
[TBL] [Abstract][Full Text] [Related]
12. Total syntheses and anticholinesterase activities of (3aS)-N(8)-norphysostigmine, (3aS)-N(8)-norphenserine, their antipodal isomers, and other N(8)-substituted analogues.
Yu QS; Pei XF; Holloway HW; Greig NH; Brossi A
J Med Chem; 1997 Aug; 40(18):2895-901. PubMed ID: 9288171
[TBL] [Abstract][Full Text] [Related]
13. Indole alkaloids from Ervatamia hainanensis with potent acetylcholinesterase inhibition activities.
Zhan ZJ; Yu Q; Wang ZL; Shan WG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6185-7. PubMed ID: 20850311
[TBL] [Abstract][Full Text] [Related]
14. Nostocarboline: isolation and synthesis of a new cholinesterase inhibitor from Nostoc 78-12A.
Becher PG; Beuchat J; Gademann K; Jüttner F
J Nat Prod; 2005 Dec; 68(12):1793-5. PubMed ID: 16378379
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.
Koteswara Rao V; Janardhan Rao A; Subba Reddy S; Naga Raju C; Visweswara Rao P; Ghosh SK
Eur J Med Chem; 2010 Jan; 45(1):203-9. PubMed ID: 19853328
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of New Galanthamine-Peptide Derivatives Designed for Prevention and Treatment of Alzheimer's Disease.
Vezenkov LT; Tsekova DS; Kostadinova I; Mihaylova R; Vassilev NG; Danchev ND
Curr Alzheimer Res; 2019; 16(3):183-192. PubMed ID: 30819081
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors.
Wang B; Mai YC; Li Y; Hou JQ; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2010 Apr; 45(4):1415-23. PubMed ID: 20079560
[TBL] [Abstract][Full Text] [Related]
18. [Galanthamine interaction with mouse brain acetylcholinesterase in in vivo experiments].
Tonkopiĭ VD; Prozorovskiĭ VB
Biull Eksp Biol Med; 1976 Jul; 82(7):823-5. PubMed ID: 953343
[TBL] [Abstract][Full Text] [Related]
19. Effect of galantamine on acetylcholinesterase and butyrylcholinesterase activities in the presence of L-carnitine in rat selected brain and peripheral tissues.
Svoboda Z; Kvetina J; Kunesová G; Herink J; Bajgar J; Bartosová L; Zivný P; Palicka V
Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():183-6. PubMed ID: 17159811
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 1,4-benzodiazepine derivatives and their biological evaluation as cholinesterase inhibitors.
Mohamed LW; El-Yamany MF
Arch Pharm Res; 2012 Aug; 35(8):1369-77. PubMed ID: 22941479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
